Search details
1.
Germline Genetic NBN Variation and Predisposition to B-cell Acute Lymphoblastic Leukemia in Children.
Blood
; 2024 Mar 06.
Article
in English
| MEDLINE | ID: mdl-38446568
2.
MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231.
Blood
; 143(20): 2053-2058, 2024 May 16.
Article
in English
| MEDLINE | ID: mdl-38457359
3.
Impact of vincristine-steroid pulses during maintenance for B-cell pediatric ALL: a systematic review and meta-analysis.
Blood
; 141(24): 2944-2954, 2023 06 15.
Article
in English
| MEDLINE | ID: mdl-36821772
4.
Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study.
Blood
; 141(7): 704-712, 2023 02 16.
Article
in English
| MEDLINE | ID: mdl-36108304
5.
Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group report.
Blood
; 141(15): 1802-1811, 2023 04 13.
Article
in English
| MEDLINE | ID: mdl-36603187
6.
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study.
Blood
; 142(24): 2069-2078, 2023 12 14.
Article
in English
| MEDLINE | ID: mdl-37556734
7.
Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia.
Blood
; 142(2): 172-184, 2023 07 13.
Article
in English
| MEDLINE | ID: mdl-37001051
8.
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium.
Blood
; 139(12): 1785-1793, 2022 03 24.
Article
in English
| MEDLINE | ID: mdl-34192312
9.
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Blood
; 140(11): 1200-1228, 2022 09 15.
Article
in English
| MEDLINE | ID: mdl-35767897
10.
Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia.
Nature
; 553(7689): 511-514, 2018 01 25.
Article
in English
| MEDLINE | ID: mdl-29342136
11.
The genetic basis and cell of origin of mixed phenotype acute leukaemia.
Nature
; 562(7727): 373-379, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30209392
12.
Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemia.
Mol Ther
; 31(4): 986-1001, 2023 04 05.
Article
in English
| MEDLINE | ID: mdl-36739480
13.
Optimizing therapy in the modern age: differences in length of maintenance therapy in acute lymphoblastic leukemia.
Blood
; 137(2): 168-177, 2021 01 14.
Article
in English
| MEDLINE | ID: mdl-32877503
14.
Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia.
Blood
; 137(3): 364-373, 2021 01 21.
Article
in English
| MEDLINE | ID: mdl-32693409
15.
Venetoclax and dinaciclib elicit synergistic preclinical efficacy against hypodiploid acute lymphoblastic leukemia.
Haematologica
; 108(5): 1272-1283, 2023 05 01.
Article
in English
| MEDLINE | ID: mdl-36700399
16.
LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemia.
Haematologica
; 2023 Dec 28.
Article
in English
| MEDLINE | ID: mdl-38152053
17.
Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement.
Haematologica
; 108(3): 717-731, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-35484682
18.
Children's Oncology Group blueprint for research: Acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 70 Suppl 6: e30585, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37489549
19.
Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1).
Pediatr Blood Cancer
; 70(11): e30609, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37553297
20.
Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631.
Pediatr Blood Cancer
; : e30467, 2023 May 31.
Article
in English
| MEDLINE | ID: mdl-37259259